UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019531
Receipt number R000022587
Scientific Title Measurement of plasma mycophenolic acid concentration using dried blood spot method.
Date of disclosure of the study information 2015/10/28
Last modified on 2018/10/30 13:01:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Measurement of plasma mycophenolic acid concentration using dried blood spot method.

Acronym

Measurement of plasma mycophenolic acid concentration using dried blood spot method.

Scientific Title

Measurement of plasma mycophenolic acid concentration using dried blood spot method.

Scientific Title:Acronym

Measurement of plasma mycophenolic acid concentration using dried blood spot method.

Region

Japan


Condition

Condition

lung transplantation

Classification by specialty

Chest surgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The plasma mycophenolic acid concentrations using dried blood spot methods and conventional pretreatment methods will be compared. The equivalency is confirmed.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The equivalency of plasma mycophenolic acid concentration

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

After lung transplant surgery
In hospital
The plasma mycophenolic acid concentration is measured by LC/MS/MS method

Key exclusion criteria

No

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nariyasu Mano

Organization

Tohoku university hospital

Division name

Department of pharmaceutical sciences

Zip code


Address

1-1 Seiryo-machi, Aoba-ku, Sendai-city, Miyagi

TEL

022-717-7525

Email

mano@hosp.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroaki Yamaguchi

Organization

Tohoku university hospital

Division name

Department of pharmaceutical sciences

Zip code


Address

1-1 Seiryo-machi, Aoba-ku, Sendai-city, Miyagi

TEL

022-717-7528

Homepage URL


Email

yamaguchi@hosp.tohoku.ac.jp


Sponsor or person

Institute

Department of pharmaceutical sciences, Tohoku university hospital

Institute

Department

Personal name



Funding Source

Organization

Management expenses grants

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Department of thoracic therapy, Tohoku university hospital

Name of secondary funder(s)

Shimadzu Corporation


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 27 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 27 Day

Last follow-up date

2018 Year 05 Month 31 Day

Date of closure to data entry

2018 Year 05 Month 31 Day

Date trial data considered complete

2018 Year 05 Month 31 Day

Date analysis concluded

2018 Year 05 Month 31 Day


Other

Other related information

Patients who were admitted to our hospital, met the selection criteria on or after October 27, 2015


Management information

Registered date

2015 Year 10 Month 28 Day

Last modified on

2018 Year 10 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022587


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name